Oculis Holding AG (NASDAQ: OCS) files Form 6-K with Q3 2025 results

Rhea-AI Filing Summary

Oculis Holding AG filed a Form 6-K to furnish its unaudited financial results for the three and nine month periods ended September 30, 2025. The filing states that detailed figures and commentary are provided in attached unaudited condensed consolidated interim financial statements, a management discussion and analysis, and a press release. It also specifies that the Form 6-K, including the financial statements and MD&A but excluding the press release, is incorporated by reference into the company’s existing registration statements on Form S-8 and Form F-3, linking these updated results to previously registered securities.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the Month of November 2025

(Commission File No. 001-41636)

Oculis Holding AG

(Translation of registrant’s name into English)

Bahnhofstrasse 20

CH-6300

Zug, Switzerland

(Address of registrant’s principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

On November 10, 2025, Oculis Holding AG (the “Registrant”) announced its unaudited results for the three and nine month periods ended September 30, 2025, which are further described in the Registrant’s Unaudited Condensed Consolidated Interim Financial Statements, Management’s Discussion and Analysis of Financial Condition and Results of Operations and press release, copies of which are attached hereto as Exhibits 99.1, 99.2 and 99.3, respectively, and are incorporated by reference herein.

The information contained in this Form 6-K, including Exhibits 99.1 and 99.2 but excluding Exhibit 99.3, is hereby incorporated by reference into the Registrant’s Registration Statements on Form S-8 (File No. 333-271938 and 333-287806) and Form F-3 (File Nos. 333-271063, 333-278409 and 333-281798).

EXHIBIT INDEX

Exhibit		Description
99.1		Unaudited Condensed Consolidated Interim Financial Statements for the Three and Nine Months Ended September 30, 2025
99.2		Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Three and Nine Months Ended September 30, 2025
99.3		Press release dated November 10, 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

				OCULIS HOLDING AG
Date: November 10, 2025				By:		/s/ Sylvia Cheung
						Sylvia Cheung Chief Financial Officer

FAQ

What does Oculis Holding AG (OCS) report in this Form 6-K?

Oculis Holding AG reports that it has announced unaudited results for the three and nine month periods ended September 30, 2025, with details provided in attached financial statements, management discussion and analysis, and a press release.

Which periods do Oculis Holding AG's unaudited results on this Form 6-K cover?

The unaudited results cover the three and nine month periods ended September 30, 2025.

What exhibits are attached to Oculis Holding AG's November 2025 Form 6-K?

The exhibits include unaudited condensed consolidated interim financial statements (Exhibit 99.1), management’s discussion and analysis of financial condition and results of operations (Exhibit 99.2), and a press release dated November 10, 2025 (Exhibit 99.3).

How is this Form 6-K used in Oculis Holding AG's existing registration statements?

The Form 6-K, including Exhibits 99.1 and 99.2 but excluding Exhibit 99.3, is incorporated by reference into Oculis Holding AG’s registration statements on Form S-8 and Form F-3.

Does the press release form part of the information incorporated into Oculis Holding AG’s registration statements?

No. The filing specifies that Exhibits 99.1 and 99.2 are incorporated by reference into the registration statements, but Exhibit 99.3, the press release, is excluded.

Who signed Oculis Holding AG's Form 6-K for the November 2025 filing?

The Form 6-K was signed on behalf of Oculis Holding AG by Sylvia Cheung, Chief Financial Officer, dated November 10, 2025.